Potential option for treating chronic kidney disease
Tuesday, January 6, 2015 - 18:40
in Health & Medicine
New clinical research indicates the drug tetrahydrobiopterin may be able to dial back over-activation of the sympathetic nervous system in chronic kidney disease. New clinical research indicates the drug tetrahydrobiopterin may be able to dial back this overactivation, leading to positive effects on the sympathetic nervous system and some measures of arterial stiffness.